Biosimilars—Curb Your Enthusiasm-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Biosimilars—Curb Your Enthusiasm

Published:2017-11-01 Issue:11 Volume:3 Page:1467
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Yang Y. Tony¹,Chen Brian²,Bennett Charles L.³

Affiliation:

1. Department of Health Administration and Policy, George Mason University, Fairfax, Virginia

2. Department of Health Services Policy and Management, University of South Carolina, Columbia

3. Center for Medication Safety and Efficacy, University of South Carolina, Columbia

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Delivery of biologics: Topical administration;Biomaterials;2023-11

2. Biosimilars: Science, Implications, and Potential Outlooks in the Middle East and Africa;Biologics: Targets and Therapy;2022-10

3. Changes in Medicare Part B Spending for Biologic Drugs After Biosimilar Entry Into the Market;JAMA Health Forum;2021-09-17

4. Improving oncology biosimilar launches in the EU, the USA, and Japan: an updated Policy Review from the Southern Network on Adverse Reactions;The Lancet Oncology;2020-12

5. Recognizing barriers to entry of biosimilars in the United States market and highlighting the solutions;Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector;2020-11-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP